Rechallenge therapy and treatment holiday: different strategies in management of metastatic colorectal cancer
Fluoropyrimidines, oxaliplatin, irinotecan and biologic therapies (Bevacizumab, Panitumumab, and Cetuximab) represent the backbone of metastatic colorectal cancer (CRC) treatment. The improvement in survival for mCRC patient led to two main outstanding issues: 1) there is a significant number of pat...
Salvato in:
| Autori principali: | , , , , |
|---|---|
| Natura: | Revisão |
| Lingua: | inglese |
| Pubblicazione: |
2013
|
| Accesso online: | https://doi.org/10.1186/1756-9966-32-92 https://jeccr.biomedcentral.com/counter/pdf/10.1186/1756-9966-32-92 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne!!
|